The study by Takeshita presented that combining serum SP-D with thrombin–antithrombin III complex, D-dimer, and plasmin-alpha2 plasmin inhibitor complex can enhance the diagnostic accuracy for AE-ILD (74). This evidence concerns the gene SFTPD and interstitial lung disease.